![Thomas Bengt Eldered](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Bengt Eldered
Gründer bei
FLERIE INVEST AB
Vermögen: 123 Mio $ am 30.06.2026
Profil
Mr. Thomas Bengt Eldered is an Independent Director at Xintela AB, a Chairman at Prokarium Holdings Ltd., a Chairman at Nanologica AB, a Chairman-Supervisory Board at Amarna Therapeutics BV, a Chairman at Recipharm Fontaine SAS, a Chairman at Flerie AB, a Chairman at Recipharm Monts SAS, a Chairman at B&E Participation, Inc., a Chairman at NorthX Biologics Matfors AB, a Chairman at Trimeta LLC, a Chairman of the board at Flerie Invest AB and a Chief Executive Officer at Consort Medical GmbH.
He is on the Board of Directors at Xintela AB, Prokarium Ltd., SymCel AB, Aesica Formulation Development Ltd., Aesica Holdco Ltd., B&E Invest AB, Bohus Biotech AB /Private Group/, Bohus HoldCo AB, Buzzard Pharmaceuticals AB, Chromafora AB, Cordivest AB, Cormorant Pharmaceuticals AB, Flerie Förvaltning AB, Flerie International AB, KAHR Medical Ltd., Pingvinen Penningplacering AB, Recipharm Holdings Ltd., Sixera Pharma AB, T&M Participation AB and Zentricity Holding AB. Mr. Eldered was previously employed as a Chairman by Cobra Biologics Holding AB, a Non-Executive Chairman by Cobra Biologics Ltd., a Vice President by Recip AB, a Factory Manager by Pharmacia AB, a Chairman by B&E Participation AB, a Deputy Director by Empros Pharma AB, and a Co-Managing Director by Recipharm Verwaltungs GmbH.
He also served on the board at Toleranzia AB, Recipharm Ltd., SwedenBIO Service AB, Recipharm AB, Backsell Eldered Holding AB, Flerie Participation AB, Provell Pharmaceuticals LLC, Roar BidCo AB, SwedenBIO Service AB and Zentricity International AB. He received his graduate degree from the University of Linköping.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FLERIE AB 67.92% | 20.05.2026 | 58’888’047 ( 67.92% ) | 123 Mio $ | 30.06.2026 |
Aktive Positionen von Thomas Bengt Eldered
| Unternehmen | Position | Beginn |
|---|---|---|
| NANOLOGICA AB | Vorsitzender | 21.05.2026 |
| XINTELA AB | Direktor/Vorstandsmitglied | 01.01.2022 |
| FLERIE INVEST AB | Gründer | 01.01.2011 |
Recipharm Holdings Ltd.
 Recipharm Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Direktor/Vorstandsmitglied | - |
Aesica Holdco Ltd.
 Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company | Direktor/Vorstandsmitglied | 04.02.2020 |
Aesica Formulation Development Ltd.
 Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Direktor/Vorstandsmitglied | 04.02.2020 |
Recipharm Monts SAS
 Recipharm Monts SAS Pharmaceuticals: MajorHealth Technology Manufactures sterile injectable anesthetic products | Vorsitzender | 20.03.2010 |
Recipharm Fontaine SAS
 Recipharm Fontaine SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorsitzender | 30.04.2014 |
Buzzard Pharmaceuticals AB
 Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Direktor/Vorstandsmitglied | - |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Thomas Bengt Eldered
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Thomas Bengt Eldered
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
55
Beziehungen ersten Grades
45
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 45 |
|---|---|
Provell Pharmaceuticals LLC
 Provell Pharmaceuticals LLC Medical DistributorsDistribution Services Markets and distributes pharmaceutical products | Distribution Services |
Recipharm AB
 Recipharm AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract development and manufacturing organization | Health Technology |
Pharmacia AB
 Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Flerie AB
 Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Recipharm Monts SAS
Recipharm Monts SAS Pharmaceuticals: MajorHealth Technology Manufactures sterile injectable anesthetic products | Health Technology |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Health Technology |
SymCel AB
 SymCel AB Medical SpecialtiesHealth Technology Develops and sells scientific instruments with accompanying consumables | Health Technology |
Aesica Formulation Development Ltd.
Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services Provides educational services | Commercial Services |
B&E Participation AB
 B&E Participation AB Pharmaceuticals: MajorHealth Technology Manufactures and provides pharmaceuticals, natural medicines, dietary supplements, and medical aids | Health Technology |
Cobra Biologics Ltd.
 Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in development of DNA-based technologies, services and products | Health Technology |
Recipharm Ltd.
 Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Recip AB
 Recip AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Zentricity International AB
 Zentricity International AB Financial ConglomeratesFinance Provides investment services | Finance |
Cobra Biologics Holding AB
 Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aesica Holdco Ltd.
Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company | Health Technology |
Xintela AB
 Xintela AB BiotechnologyHealth Technology Provides treatment and medicine for articular cartilage injuries and diseases | Health Technology |
Backsell Eldered Holding AB
 Backsell Eldered Holding AB Financial ConglomeratesFinance Provides investment services | Finance |
Cormorant Pharmaceuticals AB
 Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
B&E Invest AB | |
Toleranzia AB
 Toleranzia AB BiotechnologyHealth Technology Operates as a biotechnology company that develops drugs for the treatment of autoimmune orphan diseases | Health Technology |
Chromafora AB
 Chromafora AB Information Technology ServicesTechnology Services Develops water treatment technologies | Technology Services |
Recipharm Fontaine SAS
Recipharm Fontaine SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Empros Pharma AB
 Empros Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of overweight and obesity | Health Technology |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest invests in companies located across the globe. The firm targets companies operating in the fields of biotech and pharmaceutical companies sectors. It provide financing for early and growth stage capital requirements and takes a seat on the board. | Finance |
Bohus HoldCo AB
 Bohus HoldCo AB Chemicals: Major DiversifiedProcess Industries Manufactures and develops hyaluronic acid products | Process Industries |
Trimeta LLC | |
B&E Participation, Inc. | |
Pingvinen Penningplacering AB | |
Zentricity Holding AB
 Zentricity Holding AB Financial ConglomeratesFinance Provides investment services | Finance |
Nanologica AB
 Nanologica AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products | Health Technology |
Sixera Pharma AB
 Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Conducts research and development of pharmaceuticals treatment for Netherton syndrome | Health Technology |
Flerie Participation AB
 Flerie Participation AB Financial ConglomeratesFinance Operates as an investment holding company | Finance |
Prokarium Ltd.
 Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Develops vaccination solutions | Commercial Services |
Amarna Therapeutics BV
 Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Develops gene and immune-therapies | Health Services |
Recipharm Verwaltungs GmbH
 Recipharm Verwaltungs GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Prokarium Holdings Ltd.
 Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management services | Commercial Services |
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
Consort Medical GmbH
 Consort Medical GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Buzzard Pharmaceuticals AB
Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
Cordivest AB | |
Roar BidCo AB
 Roar BidCo AB Financial ConglomeratesFinance Functions as an investment holding company | Finance |
NorthX Biologics Matfors AB
 NorthX Biologics Matfors AB BiotechnologyHealth Technology Develops and manufactures biologics, CGT and vaccines | Health Technology |
Bohus Biotech AB /Private Group/
 Bohus Biotech AB /Private Group/ Financial ConglomeratesFinance Acts as a private group led by Flerie Invest AB and Tellacq AB | Finance |
Wählen Sie MarketScreener 
